Cite
Action and clinical significance of CCAAT/enhancer-binding protein delta in hepatocellular carcinoma.
MLA
Liu, Pengyu, et al. “Action and Clinical Significance of CCAAT/Enhancer-Binding Protein Delta in Hepatocellular Carcinoma.” Carcinogenesis, vol. 40, no. 1, Jan. 2019, pp. 155–63. EBSCOhost, https://doi.org/10.1093/carcin/bgy130.
APA
Liu, P., Cao, W., Ma, B., Li, M., Chen, K., Sideras, K., Duitman, J.-W., Sprengers, D., Tran, T. C. K., Ijzermans, J. N. M., Biermann, K., Verheij, J., Spek, C. A., Kwekkeboom, J., Pan, Q., & Peppelenbosch, M. P. (2019). Action and clinical significance of CCAAT/enhancer-binding protein delta in hepatocellular carcinoma. Carcinogenesis, 40(1), 155–163. https://doi.org/10.1093/carcin/bgy130
Chicago
Liu, Pengyu, Wanlu Cao, Buyun Ma, Meng Li, Kan Chen, Kostandinos Sideras, Jan-Willem Duitman, et al. 2019. “Action and Clinical Significance of CCAAT/Enhancer-Binding Protein Delta in Hepatocellular Carcinoma.” Carcinogenesis 40 (1): 155–63. doi:10.1093/carcin/bgy130.